| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | Kaufman Daniel Louis | HARROW, INC. | 1,907,332 | 5.4% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | HARROW, INC. | 1,808,552 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-09 | Opaleye Management Inc. | HARROW, INC. | 3,820,000 | 10.9% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | HARROW, INC. | 2,220,538 | 6.3% | EDGAR |
| SC 13G | 2024-01-09 | Private Capital Management, LLC | HARROW, INC. | - | 10.3% | EDGAR |
| SC 13G | 2023-11-24 | Kaufman Daniel Louis | HARROW, INC. | 1,885,032 | 5.4% | EDGAR |
| SC 13D/A | 2023-08-18 | BAUM MARK L | HARROW HEALTH, INC. | 3,488,361 | 9.5% | EDGAR |
| SC 13G/A | 2023-01-20 | Opaleye Management Inc. | HARROW HEALTH, INC. | 3,775,000 | 12.8% | EDGAR |
| SC 13G | 2022-02-14 | Ophir Asset Management Pty Ltd | HARROW HEALTH, INC. | 1,905,354 | 7.1% | EDGAR |
| SC 13G/A | 2022-02-10 | RENAISSANCE TECHNOLOGIES LLC | HARROW HEALTH, INC. | 1,199,112 | 4.5% | EDGAR |
| SC 13D/A | 2022-01-28 | HARROW HEALTH, INC. | Eton Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2022-01-26 | Opaleye Management Inc. | HARROW HEALTH, INC. | 3,285,000 | 12.2% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | HARROW HEALTH, INC. | 413,865 | 1.6% | EDGAR |
| SC 13D/A | 2021-04-27 | BAUM MARK L | HARROW HEALTH, INC. | - | - | EDGAR |
| SC 13G/A | 2021-02-12 | Opaleye Management Inc. | HARROW HEALTH, INC. | 9 | 11.0% | EDGAR |
| SC 13G | 2021-02-10 | RENAISSANCE TECHNOLOGIES LLC | HARROW HEALTH, INC. | 1,493,212 | 5.8% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | HARROW HEALTH, INC. | 1,532,664 | 6.0% | EDGAR |
| SC 13G/A | 2020-05-26 | Opaleye Management Inc. | HARROW HEALTH, INC. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Opaleye Management Inc. | HARROW HEALTH, INC. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Opaleye Management Inc. | HARROW HEALTH, INC. | 9 | 11.0% | EDGAR |